Condition
Pediatric Brain Tumors
Total Trials
6
Recruiting
2
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
Trial Status
Not Yet Recruiting2
Recruiting2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07703605Not Yet RecruitingPrimary
AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors
NCT07427316Not Yet RecruitingPrimary
Role of Arterial Spin Labelling Magnetic Resonance Prefusion in Grading of Pediatric Brain Tumors
NCT07417072Not ApplicableRecruitingPrimary
GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients
NCT07129317Recruiting
Pediatric Radiation Therapy Registry
NCT03451123Early Phase 1TerminatedPrimary
FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors
NCT02947373Phase 1CompletedPrimary
Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors
Showing all 6 trials